[III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 40, Issue 6, 2013, Pages 718-722

  Kurozumi, Kazuhiko ^a   Onishi, Manabu ^a   Ichikawa, Tomotsugu ^a   Fujii, Kentaro ^a   Ishida, Jyouji ^a   Shimazu, Yousuke ^a   Date, Isao ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BEVACIZUMAB; CILENGITIDE; MONOCLONAL ANTIBODY; SNAKE VENOM;

ARTICLE; CLINICAL TRIAL (TOPIC); GLIOMA; HUMAN; MOLECULARLY TARGETED THERAPY;

ANGIOGENESIS INDUCING AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; MOLECULAR TARGETED THERAPY; SNAKE VENOMS;

EID: 84882247553     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)